Previous work has shown heparin and heparan sulfates to be potent inhibitors of vascular smooth muscle cell (VSMC) growth. This laboratory has previously isolated a VSMC line insensitive to the antiproliferative action of heparin by subjecting VSMCs that grew out from rat aortic medial explants to continuous passage in media containing heparin at 200 /ig/mL. In the present study, we have isolated two additional heparin-resistant ( 
H eparin is a potent antiproliferative agent for vascular smooth muscle cells (VSMCs) both in vitro and after vascular injury.
1 ' 2 Heparin is a highly charged glycosaminoglycan composed of repeating disaccharide units of alternating glucosamine and iduronic or glucuronic acid residues that are heterogeneously modified with carboxylate and N-or 0-linked sulfate groups. 3 It has been shown that heparin treatment inhibits intimal hyperplasia, which develops after endothelial denudation of carotid arteries. 1 Anticoagulant and nonanticoagulant heparins are equally effective in abolishing VSMC proliferation in vivo and in vitro. 4 -5 Endogenous heparan sulfates are potentially fundamental physiological regulators of VSMC growth, because VSMC growth-inhibitory heparan sulfates are produced by confluent endothelial cells and VSMCs. 6 -Heparin has two effects on the G O -»S transition. Heparin reduces the number of cells entering the cell cycle from G o and also delays the entry of cells into the S phase. 11 Heparin suppresses the serum-stimulated accumulation of c-fos and c-myc proto-oncogene mRNA in both rat and calf VSMCs. 12 Experiments suggest that protein kinase C-dependent but not protein kinase C-independent growth factor signaling pathways for c-fos and c-myc mRNA expression are selectively sensitive to inhibition by heparin. 13 Additional effects of heparin on gene expression later in the cell cycle have also been noted, including inhibition by heparin of histone H3, c-myb, and 2F1 mRNA levels 14 and stimulation of the expression of type III and, to a lesser extent, type V collagen and fibronectin mRNAs in cultured VSMCs.
phenotype in intimal cells, with decreased myofilament and SMC-specific actin and myosin levels 16 - 17 and increased tenascin expression. 18 Heparin treatment both inhibits growth and drives VSMCs toward a contractile phenotype, as it promotes the expression of SMC a-actin in cultured VSMCs 19 - 20 and in vivo after carotid artery injury. 21 Heparin treatment of VSMCs does not affect the overall rate of protein synthesis; however, heparin enhances the accumulation of several proteins, including apolipoprotein E 22 and a 60,000-molecular weight (MW) collagen, 23 and decreases the amount of a 48,000-MW protein in substrate-attached material 24 and a protein that is immunologically related to major secreted protein. 25 The role, if any, of these metabolic changes in the antiproliferative mechanisms of heparin's action is not known. 26 Thus, although heparin has numerous effects on VSMCs, the cellular mechanisms that are vital for heparin's inhibition of proliferation and stimulation of differentiation have not been identified. In this article we show that heparin-resistant (HR) cells may be selected from the VSMC population and that these cells differ significantly from heparin-sensitive VSMCs in growth and metabolic characteristics. These experiments may be relevant to understanding the loss of VSMC growth control that leads to vascular pathologies and the cellular and molecular mechanisms that underlie the regulation of VSMC growth and differentiation by heparin and heparan sulfates.
Methods

Cell Culture
SMCs were isolated from abdominal aortas of Sprague-Dawley rats. A 1-2-cm segment of aorta was removed from the animal and opened longitudinally, the endothelial cell layer was dislodged with a stream of Hanks'-N-2-hydroxyethylpiperazine-./V'-2-ethanesulfonic acid (HEPES), and the SMC layer was dissected free of the adventitia. VSMCs were isolated by placing explants anchored under metal grids in 20% fetal calf serum (FCS)/RPMI with penicillin, streptomycin, and fungizone supplements and cultured in a humidified incubator at 37°C and a 5% CO 2 atmosphere. VSMCs grew out from the explant within 4-6 weeks. Explants were then discarded and the monolayers of SMCs were passaged. Control VSMCs were used from passages 6-12. HR cells (cells that are not growth inhibited by heparin) were isolated by placing explants in growth media containing heparin (200 /Ag/mL), followed by approximately 15 passages in heparin-containing media. The HR cells were subsequently passaged in normal growth media.
Clonal cell lines were derived from the resistant cell population by plating cells in 24-well multiwell tissue culture dishes at densities of approximately 1 cell/well. Cell cultures were examined 12 hours later, and only those wells containing single cells were allowed to grow until cell numbers had increased to densities suitable for their subsequent passage.
Analysis of Growth Rate and Heparin Inhibition
To measure the growth rate of cells, VSMCs were plated in 12-well multiwell tissue culture plates at densities of =10 4 -free Hanks'-HEPES (CMFH) and were released from the dish by trypsinization, and cell number was determined using a Coulter counter. Percent growth inhibition of proliferation was expressed as 
Effect of Conditioned Medium on Growth
To assess the presence of secreted growth factors or inhibitors in cell-conditioned medium, normal or resistant cell cultures were grown to approximately equal densities in 20% FCS/RPMI or 0.4% FCS/RPMI for 48 hours. Culture medium from each cell type was collected, filtered (0.45 /Am), and added directly to growth-arrested normal VSMCs, and cell numbers were determined after 4 days. In some cases the 20% FCS-conditioned medium was diluted 1:1 with fresh 20% FCS/RPMI to replenish the nutrients and then tested for its effects on growth. Additionally, some cultures were grown in 20% FCS plus heparin (200 /xg/mL), and conditioned media from the cultures were tested for their effect on the growth of normal cells.
Growth in Soft Agar
To assess anchorage-independent growth of normal and HR VSMCs, cells were tested for their ability to grow in soft agar, as previously detailed. 27 After 14 days of growth in soft agar, colonies were observed by phase-contrast microscopy of living cultures and measured using an ocular micrometer. Colonies >0.2 mm in diameter were considered transformed. 28 
Heparin Binding and Uptake
To examine heparin binding and internalization by VSMCs, cells at subconfluent densities were growth arrested by culture in 0.4% FCS/RPMI media for 3 days, and heparin binding was studied using a modification of a published procedure. 9 3 H-Heparin (10 Aig/mL, 0.24 mCi/mg; New England Nuclear, Boston, Mass.) in 20% FCS/RPMI was added to cells at 37°C for 0-6 hours, and cells were then washed with CMFH and released from culture surfaces by trypsinization for 5 minutes at 37°C. Cells were centrifuged at 5,000 rpm for 5 minutes, cell surface-associated (supernatant) and cell-incorporated (cell pellet) pools were solubilized with 1% sodium dodecyl sulfate (SDS)/0.2N NaOH, and isotope levels were quantified by liquid scintillation counting. In some samples, a 50-fold excess of heparin was added to the cells immediately before addition of 3 H-heparin to determine the levels of nonspecific binding.
Morphological Studies
To examine the morphology of VSMCs at the lightmicroscope level, cells were grown for 48 hours in 20% FCS/RPMI with or without 200 /Ag/mL heparin. Cells were fixed in 3.7% formaldehyde/phosphate-buffered saline and stained with crystal violet or new magenta.
To examine the ultrastructure of VSMCs, cells were plated at subconfluent densities on glass coverslips, grown in 20% FCS for 48 hours, washed in Hanks'-HEPES, and fixed in 2% glutaraldehyde in cacodylate buffer (0.1 M cacodylate and 5% sucrose [pH 7.2]) for 60 minutes at room temperature. Coverslips were washed three times in cacodylate buffer, postfixed in 2% OsO 4 in cacodylate buffer for 60 minutes at 4°C, and then washed three times in cacodylate buffer. Coverslips were dehydrated in an ascending series of ethanol concentrations, critical-point dried, mounted on a stub, and sputter coated for 2.5 minutes at 8 mA/11 V. Samples were observed and photographed using scanning electron microscopy.
Protein Analysis
VSMCs were cultured in 20% FCS/RPMI; after 44 hours cells were washed with warm Hanks'-HEPES, switched to methionine-free RPMI containing 2% FCS and 50 fiCi/mh 35 S-methionine (Translabel, ICN, Costa Mesa, Calif.), and incubated for an additional 4 hours. To isolate secreted proteins, the culture media were collected and cells rinsed two times with 1.5 mL phosphate-buffered saline, which was removed and pooled with the culture media and to which was added a 1/10 volume of extraction solution (10 raM phenylmethylsulfonyl fluoride, 100 mM Af-ethylmaleimide, 25 mM EDTA, and 500 mM tris(hydroxymethyl)aminomethane chloride [Tris • Cl] [pH 7.5]). A 1/10 volume of cold 100% trichloroacetic acid was added to the media samples, which remained at 4°C for 30 minutes. Precipitated proteins were then pelleted by centrifugation at 10,000 rpm for 20 minutes. Pellets were rinsed in 70% ethanol and resuspended in electrophoresis sample buffer (10 mM Tris • Cl [pH 8.0], 1 mM EDTA, 1% SDS, 10% glycerol, and 5% /3-mercaptoethanol). To isolate cell layer-associated proteins, cell layers were scraped from dishes into electrophoresis sample buffer, and samples were stored at -20°C. Samples were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using 4% acrylamide stacking gels and 8% or 10% separating gels, and proteins were visualized by autoradiography. MWs of labeled proteins were estimated by comparing their migration distances (R { ) with those of protein standards (Bio-Rad, Richmond, Calif.), using linear regression analysis based on a log Af r versus R t plot.
Heparin Affinity Chromatography
Proteins were metabolically labeled with 35 S-methionine and isolated as described above. Samples were passed over PD-10 desalting columns (Pharmacia, Piscataway, N.J.) equilibrated and eluted with chromatography running buffer (10 mM Tris [pH 8 .0] and 0.1 M NaCl). Affinity chromatography was carried out using heparin-Sepharose affinity columns (Pharmacia) with a step gradient salt elution. Protein fractions from flowthrough (chromatography running buffer) and 0.1-0.5, FCS/RPMI, and cytospun onto slides. The cells were washed twice in cold phosphate-buffered saline, fixed in 2% paraformaldehyde/phosphate-buffered saline at 4°C for 20 minutes, washed twice with phosphate-buffered saline and twice with water, and stored at -20°C with desiccant. Immunocytochemistry was performed using an anti-smooth muscle a-actin antibody (Sigma), and visualization was achieved with the Vectastain ABC detection system (Vector Laboratories, Burlingame, Calif.). Cells were counterstained with Harris's hematoxylin.
Results
Isolation of HR VSMCs
To date, three HR VSMC lines have been independently derived from aortic smooth muscle explants. These lines were initiated and maintained in growth media containing high levels of heparin (200 jig/mL) as described in this article and in Pukac et al, 12 in which the first isolated HR cell line (HR1) was reported. The cell lines studied in this report include the first and second HR VSMC lines isolated (HR1 and HR2 cells, respectively) that at passage numbers >20 were <10% growth inhibited by heparin at 200 /ig/mL (Figure 1 ). The third HR VSMC line established (HR3) was tested for heparin sensitivity at various passages: at passage number 12, these cells exhibited =55% growth inhibition by heparin at 200 ^g/mL; at passage 16, =40% effect; and at passage 36, =10% inhibition ( Figure 1 ). Heparin at 200 /xg/mL typically inhibits the growth of normal VSMCs by «80% 7 ; thus, the HR cell lines showed approximately a twofold to 15-fold decrease in heparin sensitivity. We also found that normal VSMCs grown in the absence of heparin to high passage numbers (>25) are still significantly growth inhibited by heparin (data not shown). These findings demonstrate that selective pressure by growth in heparin, and not high passage, is one determining factor for heparin resistance in these experiments. In this study we undertook a series of experiments to study the growth and differentiation characteristics of the HR cells and to explore the possible mechanisms underlying their unique insensitivity to heparin's antiproliferative activity. 
Morphology
The morphology of the HRl and HR2 cells was substantially different from that of normal, heparinsensitive VSMCs (Figures 2A and 2B ). Both HRl and HR2 cells appeared significantly smaller than heparinsensitive VSMCs. In addition, cells from both HR lines appeared spindle shaped and contained more elongated processes than control cells. HRl cell cultures studied by light microscopy showed significant alterations in cell-cell contact. Whereas normal VSMCs grew in clusters or aggregates of cells with extensive cell-cell contacts ( Figure 2C ), the HRl cells showed infrequent contacts that were very focal, giving rise to a lattice-like arrangement of cells in cultures at subconfluent densities ( Figure 2D ). Interestingly, supplementation of HRl cultures with heparin (200 ju,g/mL) promoted cell aggregation or decreased migration, making these cultures resemble a more normal phenotype ( Figure 2E ).
Differentiation
The differentiated phenotype of HR cells was studied by examining the expression of SMC a-actin, which is an accepted marker of SMC differentiation. 19 For this purpose, normal and HR VSMCs were growth arrested for 2 days, removed from culture surfaces with trypsin/ EDTA, and cytospun onto glass slides. SMC-specific actin expression was detected immunocytochemically by using a monoclonal anti-SMC a-actin antibody. SMC a-actin expression was observed in nearly all of the normal VSMCs (Figure 3A) , in a small fraction of the HRl cells ( Figure 3B ), and in a substantial fraction of the HR2 and HR3 cells ( Figure 3D and Table 1 ). As heparin is a known differentiation-promoting agent for VSMCs, we tested this action of heparin on the HR cells. Interestingly, HRl cells fed culture medium with heparin (200 fig/mL) for 2 days showed a significant increase in the percentage of SMC-specific, actin-positive cells (compare Figure 3B with 3C ; also see Table 1 ). To more easily observe heparin's effect on the differentiation of HR2 cells, it was necessary to use proliferating cultures, which contain fewer actin-expressing cells than do the growth-arrested cells. Heparin treatment of these cultures also resulted in a marked increase in the percentage of cells expressing SMC actin (i.e., compare panels E and F in Figure 3 ; also see Table 1 ).
Growth Characteristics
To determine whether growth characteristics were altered in HR cells compared with normal cells, growth rates in monolayer cultures and growth in response to PMA were determined. Resistant cells and normal VSMCs were plated in 20% FCS/RPMI and after 4 hours were switched to new 20% FCS media or 0.4% FCS/RPMI. Cell numbers were determined every 24 hours for 4 days ( Figure 4A ). Resistant cells grew at a faster rate and to greater cell densities than did normal cells. We also observed that resistant cells were growth arrested in 0.4% FCS-containing medium, indicating that these cells did not show growth independence in the absence of serum. However, their ability to grow at very high densities indicates that they were not as sensitive to cell contact inhibition as the normal VSMCs. In addition, we found that the HR cultures were mitogenically responsive to the phorbol ester PMA, whereas control VSMCs were not ( Figure 4B ).
Resistant cells were found to have increased growth rates compared with normal cells, suggesting that these cells may produce elevated levels of autocrine growth factors. To analyze the effect of secreted products from resistant VSMCs on the growth of normal VSMCs, resistant and normal cells were cultured in 0.4% or 20% FCS/RPMI for 48 hours, and culture media were collected. Cell numbers were determined to ensure that the media were obtained from cultures of approximately equal density. Normal VSMCs were cultured in 20% conditioned medium or in 20% conditioned medium mixed with an equal volume of fresh 20% FCS/RPMI to replenish the nutrients, and cell numbers were counted after 4 days ( Figure 4C ). Conditioned media from normal and resistant cells stimulated approximately the same amount of cell growth, suggesting that resistant cells were not secreting larger amounts of growth factors than the normal VSMCs. Second, conditioned media were collected from resistant cells treated with 20% FCS/RPMI ±200 f i g/mL heparin and were fed to normal cells. Normal cell growth was significantly less (55%) in the conditioned medium containing heparin, indicating that resistant cells do not degrade heparin to a great enough extent to account for their insensitivity to heparin (data not shown).
Based on the altered growth properties of HR cells described above, the ability of the cells to grow in soft agar was determined. It was found that the majority of HRl and HR2 cells formed colonies in soft agar, and of these, at least 15% grew to >0.2 mm in diameter after 2 weeks of soft agar culture, indicating that these HR populations contain a significant percentage of cells that display the classical transformed phenotype. 28 Normal VSMCs and HR3 cells did not form colonies in soft agar culture.
Heparin Binding and Internalization
Studies have shown that VSMCs contain cell-surface, high-affinity heparin binding sites and that heparin is rapidly internalized by these cells. 9 To determine whether heparin insensitivity is a result of deficiencies in heparin binding or uptake, heparin binding and internalization were measured in HRl cells. Normal and resistant VSMCs were growth arrested, and 20% FCS/RPMI containing 10 ^ig/mL 3 H-heparin was added. 
FIGURE 4. Control and heparin-resistant (HR) HRl cells differ in several growth
.4% FCS/RPMI (Q), 20% FCS/RPMI (S), conditioned media from control (C) or HRl (R) cells, or 20% FCS/RPMI mixed 1:1 with control (CIS) or HRl (R/S) conditioned media. Cell number of triplicate samples was determined after 4 days. Panel D: Photomicrographs showing that HRl and HR2 but not control or HR3 vascular smooth muscle cells form colonies when cultured in soft agar. Shown are control and HRl cells cultured in soft agarfor 14 days. Cultures were examined for colony formation by phase-contrast microscopy.
At 0, 1, and 6 hours after stimulation, two fractions consisting of cell surface-bound heparin and internalized heparin were measured ( Figure 5 ). The levels of surface-bound heparin rose slightly over 1 hour and leveled off, while the levels of internalized heparin increased at a steady rate during this time in both cell types. For both normal and HR cells, levels of nonspecific binding and uptake of radiolabeled heparin averaged =20% of total binding/uptake (not shown). The data suggest that insensitivity of resistant cells to heparin is not related to differences in the binding and internalization of heparin.
Protein Biosynthesis
To identify those factors such as heparin-binding proteins that might play a role in the insensitivity of HR cells to heparin, differences in the relative abundance of proteins produced by normal and HRl VSMCs were analyzed. Proliferating cells were labeled with 35 S-methionine, and proteins from the culture medium and cell layer were isolated and analyzed by SDS-PAGE and autoradiography ( Figure 6A ). Although the vast majority of protein bands were identical between normal and HR cells, in three experiments several proteins were identified that are preferentially produced in either normal or resistant cells, including proteins of approximate M r of 120,000 and 38,000 in a normal cell layer; 97,000 and 38,000 in normal culture media, and 40,000 and 31,000 in HRl culture media.
Previous work has implicated the role of heparinbinding growth factors or extracellular matrix components in mediating heparin's antiproliferative activity (e.g., see Jackson et al 26 ). Thus, to study the importance of heparin-binding proteins in the regulation of the heparin-insensitive phenotype of HR cells, cell layer and culture medium proteins from 35 S-methionine-labeled normal VSMC or HR1 cultures were isolated and passed over a heparin affinity column, and heparinbinding proteins were eluted with a 0.1-2 M NaCl gradient. Several heparin-binding proteins were detected in all samples from both cell types. Especially notable was an =38,000-MW secreted protein, which bound strongly to heparin and was present at much higher levels in normal VSMC culture media compared with the HR VSMC culture media ( Figure 6B ).
Clonal Heterogeneity
The resistant cell populations were heterogeneous in that only a fraction of the cells expressed SMC-specific actin. To investigate the relation between SMC a-actin expression and heparin sensitivity in HR cells, we examined these parameters in HRl-derived clonal cell lines. Eighteen clones were derived from the population by using the limiting dilution plating method. We observed that individual clones showed distinct cellular morphologies (not shown) and a wide variance ( < 1 -90%) in their percentage of SMC a-actin-expressing cells (Figure 7) . None of the clonal populations were completely negative for SMC actin; thus, SMC a-actin expression by the original HR1 population is probably a dynamic feature regulated by specific environmental cues. In fact, these observations suggest that many or all of the HR1 cells have the potential to express SMC actin. This expression is potentiated by growth arrest and heparin treatment and may depend on other variables such as cell-cell interactions or cell cycle position. We also examined the heparin sensitivity of the clonal cell lines. Interestingly, the majority (16/18) of the clonal populations displayed =0-20% growth inhibition by heparin (200 /xg/mL), with one clone at =37% inhibition, whereas the parent HR1 cell line showed =3% growth inhibition (Figure 1) , suggesting that the clones most resistant to heparin's antiproliferative ac- tivity predominate in the parental cell line. Since these cells were routinely passaged during cloning in heparinfree media, it appears that heparin resistance is a stable characteristic; i.e., cells did not revert to being heparin sensitive when the selective pressure was lifted. may be key physiological inhibitors of cell growth. Yet the exact mechanism of heparin's antiproliferative action remains unknown. Here we report the isolation of VSMC lines from aortic medial explants that are resistant to the antiproliferative activity of heparin. These findings suggest the possibility that a subpopulation of HR VSMCs may reside within the media of the blood vessel wall or that normal medial VSMCs may have the potential for becoming heparin insensitive, given the necessary environmental cues. The presence or induction of the HR cell phenotype in the blood vessel may be one mechanism by which vascular proliferative lesions arise, despite the abundance of endothelial or SMC-derived growth inhibitors such as the heparan sulfates. A physiological correlate to our selected HR cells is the VSMCs derived from spontaneously hypertensive rats, which are markedly less susceptible to growth inhibition by heparin compared with normotensive, control Wistar-Kyoto rat-derived VSMCs. 10 Unlike the HRl cells in the present study, however, the spontaneously hypertensive rat VSMCs had a reduced capacity for binding heparin, even though spontaneously hypertensive rat and Wistar-Kyoto rat VSMCs did not differ with respect to the early kinetics of heparin internalization.
Discussion
We have tested several hypothetical mechanisms to explain the heparin insensitivity of the HR cells. First, it was shown that in two respects the availability of heparin to the HR cells appeared to be largely similar. We demonstrated that for both control VSMCs and HRl cells, similar amounts of heparin were bound by cell surfaces and internalized. Additionally, it was shown that heparin, even after exposure to HRl cultures, still retained its antiproliferative effects on normal VSMCs. Therefore, the HRl cells did not appear to degrade heparin to a significant extent. We also tested HRl cells for their ability to produce autocrine factors that might counteract the activity of heparin. It was found that culture media conditioned by HRl cells failed to stimulate growth of normal VSMCs beyond that observed in conditioned media from normal VSMC cultures. These observations suggest that the heparin insensitivity of the HR cells may reflect a more subtle selective adaptation in the HR cells.
Numerous studies have shown that the phenotype of SMCs can vary between states characterized by low proliferation rates and high levels of SMC actin expression and those exhibiting high growth rates and low levels of actin expression. Studies have shown that heparin can induce the differentiated phenotype in VSMCs and suggest that removal of heparan sulfate from the SMC extracellular matrix may be one trigger that initiates SMC phenotypic change in vitro and in vivo.
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- 30 One of our most intriguing findings was that in HR cells, their differentiation as measured by SMC a-actin levels was influenced by heparin, whereas growth was not. Thus, the differentiation effects of heparin on VSMCs are distinct from its growth effects. The relation between the differentiation state of the cells and heparin sensitivity was also studied by using clonal cultures derived from the HRl cell line. In clonal cultures of HR cells, the levels of SMC actin staining did not correlate with the sensitivity of these cultures to growth inhibition by heparin. These data show that heparin sensitivity of HR cells is independent of their differentiation state; however, this conclusion should be tempered by the fact that even the most heparinsensitive HR clones do not show normal levels of heparin sensitivity. The HR cells should be of great use to further examine the differentiation-promoting effect of heparin, separate from its growth effects.
We observed that the HR cells displayed significantly different growth characteristics compared with control VSMCs. The combination of the loss of heparin sensitivity and enhanced responsiveness to mitogens, as observed with PMA, could act synergistically to allow uncontrolled proliferation of HR cells. Both HR1 and HR2 cells but not normal VSMCs formed colonies when cultured in soft agar, indicating that these resistant cell lines have some characteristics of transformed cells. Other investigators have transformed VSMCs with SV40 large T antigen, which results in immortalization and altered growth rates, but those cells remained sensitive to heparin's growth inhibition, 31 indicating that transformation does not necessarily confer heparin resistance. Finally, the fact that the HR3 cell line does not appear to be transformed shows that heparin insensitivity is independent of the transformed state.
Studies examining the total proteins produced by normal and HR VSMCs have identified one potential mediator of heparin insensitivity. Very significant differences were observed in the amounts of several specific proteins produced in normal versus HR VSMCs. Of particular interest was the expression of a heparin-binding protein of a 38,000 M r , which was present in the culture media of normal cells but was not detected in the media of HR cell cultures. One potential role for the 38,000-MW protein produced by normal VSMCs may be to associate with cell-surface heparan sulfate proteoglycans or exogenously added heparin, thereby promoting the cell-cell interactions that are important for cell contact growth inhibition. Alternatively, the 38,000-MW protein may have autocrine growth-promoting activities that are neutralized by heparin; HR cells may use altered mechanisms for growth that do not include the 38,000-MW protein. We are currently attempting to identify the 38,000-MW protein produced by normal VSMCs. Known SMC heparinbinding proteins of =38,000 MW include sulfated glycoprotein 4, 32 -33 a heparan sulfate-binding protein, 34 and apolipoprotein E. 24 One future aim is to assess the significance of the =38,000-MW protein in mediating heparin sensitivity of VSMCs.
Future investigations with the three HR VSMC lines will contribute to our understanding of the pathological relevance of heparin insensitivity and will greatly facilitate understanding of the mechanism of action of heparin in regulating the growth and differentiation of VSMCs.
